Brf-Brasil Foods S.A. (BRFS) 16.84 $BRFS SmarTrend

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Brf-Brasil Foods S.A. (BRFS) 16.84 $BRFS

SmarTrend Watching for Potential Pullback in Shares of BRF - Brasil Foods After 1.49% Gain
Comtex SmarTrend(R) - Thu Aug 25, 1:53PM CDT
BRF - Brasil Foods (NYSE:BRFS) traded in a range yesterday that spanned from a low of $16.73 to a high of $17.11. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $16.89 on volume of 642,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BRFS: 16.84 (+0.37)

Look for Shares of BRF - Brasil Foods to Potentially Pullback after Yesterday's 1.66% Rise
Comtex SmarTrend(R) - Tue Aug 09, 3:22PM CDT
BRF - Brasil Foods (NYSE:BRFS) traded in a range yesterday that spanned from a low of $16.79 to a high of $17.37. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $16.93 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
BRFS: 16.84 (+0.37)

Upgrade Alert for BRF - Brasil Foods (BRFS)
Comtex SmarTrend(R) - Wed Jun 01, 3:18AM CDT
BRF - Brasil Foods (NYSE:BRFS) was upgraded from Neutral to Overweight at JP Morgan today. The stock closed yesterday at $12.50 on volume of 2.6 million shares, above average daily volume of 1.5 million. There is potential upside of 31.1% for shares of BRF - Brasil Foods based on a current price of $12.50 and an average consensus analyst price target of $16.39. BRF - Brasil Foods shares should first meet resistance at the 50-day moving average (MA) of $13.94 and find additional resistance at the 200-day MA of $15.54.
BRFS: 16.84 (+0.37)

Look for Shares of BRF - Brasil Foods to Potentially Rebound after Yesterday's 3.75% Sell Off
Comtex SmarTrend(R) - Mon May 23, 4:10PM CDT
BRF - Brasil Foods (NYSE:BRFS) traded in a range yesterday that spanned from a low of $12.56 to a high of $12.84. Yesterday, the shares fell 3.8%, which took the trading range below the 3-day low of $12.72 on volume of 937,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
BRFS: 16.84 (+0.37)

Active Equities to Watch in the Consumer Goods Sector -- Tyson Foods, Hormel Foods, BRF S.A., and ACCO Brands
ACCESSWIRE - Wed Feb 03, 7:02AM CST
NEW YORK, NY / ACCESSWIRE / February 03, 2016 / Park Lane Advisor has initiated coverage on the following equities: Tyson Foods Inc. (NYSE: TSN), Hormel Foods Corporation (NYSE: HRL), BRF S.A. (NYSE: BRFS), and ACCO Brands Corporation (NYSE: ACCO). Free research report on Tyson Foods can be accessed at http://www.parklaneadvisor.com/ On Tuesday, February 02, 2016, the NASDAQ Composite ended at 4,516.95, down 2.24%, the Dow Jones Industrial Average declined 1.80%, to finish the day at 16,153.54, and the S&P 500 closed at 1,903.03, down 1.87%. Register for your complimentary reports at the links given below.
BRFS: 16.84 (+0.37), ACCO: 10.34 (+0.22), HRL: 38.46 (+0.25), TSN: 76.44 (+0.96)

BRF - Brasil Foods Shares Down 40.9% Since SmarTrend's Sell Call (BRFS)
Comtex SmarTrend(R) - Fri Jan 29, 5:41PM CST
SmarTrend identified a Downtrend for BRF - Brasil Foods (NYSE:BRFS) on July 1st, 2015 at $20.54. In approximately 7 months, BRF - Brasil Foods has returned 40.93% as of today's recent price of $12.13.
BRFS: 16.84 (+0.37)

BRF - Brasil Foods Has Returned 43.9% Since SmarTrend Recommendation (BRFS)
Comtex SmarTrend(R) - Fri Jan 22, 4:53PM CST
SmarTrend identified a Downtrend for BRF - Brasil Foods (NYSE:BRFS) on July 1st, 2015 at $20.54. In approximately 7 months, BRF - Brasil Foods has returned 43.90% as of today's recent price of $11.52.
BRFS: 16.84 (+0.37)

Shares of BRFS Down 42.0% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Fri Jan 15, 11:40AM CST
SmarTrend identified a Downtrend for BRF - Brasil Foods (NYSE:BRFS) on July 1st, 2015 at $20.54. In approximately 7 months, BRF - Brasil Foods has returned 41.95% as of today's recent price of $11.92.
BRFS: 16.84 (+0.37)

New Information Reveals Opportunity in Volatility -- Featured Research on Canadian Natural Resources, Diamond Offshore Drilling, BRF and SeaWorld Entertainment
ACCESSWIRE - Tue Jan 12, 7:10AM CST
NEW YORK, NY / ACCESSWIRE / January 12, 2016 / Moments ago, Trader's Choice released new research updates concerning several important developing situations including the following equities: Canadian Natural Resources Ltd. (NYSE: CNQ), Diamond Offshore Drilling Inc. (NYSE: DO), BRF SA (NYSE: BRFS) and SeaWorld Entertainment Inc. (NYSE: SEAS). Trader's Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
DO: 16.28 (-0.23), SEAS: 13.17 (+0.09), BRFS: 16.84 (+0.37), CNQ: 31.85 (+0.68)

BRF - Brasil Foods Down 36.7% Since SmarTrend Downtrend Call (BRFS)
Comtex SmarTrend(R) - Fri Jan 08, 9:18AM CST
SmarTrend identified a Downtrend for BRF - Brasil Foods (NYSE:BRFS) on July 1st, 2015 at $20.54. In approximately 6 months, BRF - Brasil Foods has returned 36.69% as of today's recent price of $13.00.
BRFS: 16.84 (+0.37)

BRF - Brasil Foods Shares Down 32.7% Since SmarTrend's Sell Call (BRFS)
Comtex SmarTrend(R) - Thu Dec 31, 6:18PM CST
SmarTrend identified a Downtrend for BRF - Brasil Foods (NYSE:BRFS) on July 1st, 2015 at $20.54. In approximately 6 months, BRF - Brasil Foods has returned 32.70% as of today's recent price of $13.82.
BRFS: 16.84 (+0.37)

BRF - Brasil Foods Down 27.1% Since SmarTrend Downtrend Call (BRFS)
Comtex SmarTrend(R) - Thu Dec 24, 5:04PM CST
SmarTrend identified a Downtrend for BRF - Brasil Foods (NYSE:BRFS) on July 1st, 2015 at $20.54. In approximately 6 months, BRF - Brasil Foods has returned 27.15% as of today's recent price of $14.96.
BRFS: 16.84 (+0.37)

28.6% Return Seen to Date on SmarTrend BRF - Brasil Foods Call (BRFS)
Comtex SmarTrend(R) - Thu Dec 17, 4:08PM CST
SmarTrend identified a Downtrend for BRF - Brasil Foods (NYSE:BRFS) on July 1st, 2015 at $20.54. In approximately 6 months, BRF - Brasil Foods has returned 28.61% as of today's recent price of $14.66.
BRFS: 16.84 (+0.37)

BRF - Brasil Foods Has Returned 26.6% Since SmarTrend Recommendation (BRFS)
Comtex SmarTrend(R) - Thu Dec 10, 10:09AM CST
SmarTrend identified a Downtrend for BRF - Brasil Foods (NYSE:BRFS) on July 1st, 2015 at $20.54. In approximately 5 months, BRF - Brasil Foods has returned 26.56% as of today's recent price of $15.08.
BRFS: 16.84 (+0.37)

BUYINS.NET: BRFS, LYV, CCOI, IHF, CVLT, PTH Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Wed Dec 02, 5:40PM CST
November 24, 2015
IHF: 123.69 (+1.61), PTH: 48.43 (+0.64), CCOI: 36.16 (+0.93), BRFS: 16.84 (+0.37), CVLT: 52.25 (+0.13), LYV: 27.07 (+0.30)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 135

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 35

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 20

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 78

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 29

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 194

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 119

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 117

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 59

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading

Top 5 Most Recently Viewed Articles

Ocuphire Pharma Faces Scrutiny Over Shareholder Obligations

Updated Category News Views 81

Ocuphire Pharma Under Investigation by Ademi LLP Recently, there have been growing concerns regarding the fiduciary responsibilities of Ocuphire Pharma, Inc. (NASDAQ: OCUP) to its public shareholders. Ademi LLP has initiated an investigation focused on whether the company is adequately protecting the interests of its shareholders amidst its dealings with Opus Genetics....

Continue Reading
Investigation Into Shareholder Claims Against AMLX, FIVE, HUM, and VSTS

Updated Category News Views 190

Grabar Law Office Investigates Shareholders' Rights Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Vestis Corp. (NYSE: VSTS) shareholders may have claims worth exploring. Grabar Law Office wants to inform these shareholders about the ongoing investigations into potential securities fraud that could have affected...

Continue Reading
Investors Seek Recovery in Class Action Against Paragon 28, Inc.

Updated Category News Views 109

Class Action Lawsuit Filed for Paragon 28, Inc. Investors We are reaching out to inform investors about an important class action securities lawsuit involving Paragon 28, Inc. This initiative aims to recover losses for investors who may have been adversely affected by purported securities fraud associated with the company. Details of the Class Action The class action...

Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results

Updated Category News Views 165

Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...

Continue Reading
Phare Bio Secures $27 Million to Revolutionize Antibiotic Discovery

Updated Category News Views 226

Phare Bio scored big back in 2024 with up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). This isn’t just pocket change; it’s a lifeline aimed at supercharging their generative artificial intelligence (AI) platform. Teaming up with MIT's Collins Lab and Harvard's Wyss Institute, they set their sights on developing new classes...

Continue Reading